Pre-Transplant Hypoalbuminemia Is Not Associated With Early Key Outcomes Among Simultaneous Pancreas and Kidney Transplant Recipients

The role of pre-transplant hypoalbuminemia and its impact on post-transplant outcomes in patients undergoing simultaneous pancreas-kidney (SPK) transplantation remains unclear. We analyzed all SPK recipients at our center, who had at least 2 weeks of pancreas and kidney graft survival and had serum...

Full description

Saved in:
Bibliographic Details
Main Authors: Ekaterina Fedorova, Sofia Nehring Firmino, Dixon B. Kaufman, Jon S. Odorico, David Aufhauser, Carrie Thiessen, David P. Al-Adra, Didier Mandelbrot, Brad C. Astor, Sandesh Parajuli
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Transplant International
Subjects:
Online Access:https://www.frontierspartnerships.org/articles/10.3389/ti.2025.14091/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832593394595004416
author Ekaterina Fedorova
Sofia Nehring Firmino
Dixon B. Kaufman
Jon S. Odorico
David Aufhauser
Carrie Thiessen
David P. Al-Adra
Didier Mandelbrot
Brad C. Astor
Brad C. Astor
Sandesh Parajuli
author_facet Ekaterina Fedorova
Sofia Nehring Firmino
Dixon B. Kaufman
Jon S. Odorico
David Aufhauser
Carrie Thiessen
David P. Al-Adra
Didier Mandelbrot
Brad C. Astor
Brad C. Astor
Sandesh Parajuli
author_sort Ekaterina Fedorova
collection DOAJ
description The role of pre-transplant hypoalbuminemia and its impact on post-transplant outcomes in patients undergoing simultaneous pancreas-kidney (SPK) transplantation remains unclear. We analyzed all SPK recipients at our center, who had at least 2 weeks of pancreas and kidney graft survival and had serum albumin measured within 45 days pre-transplant. Recipients were categorized based on pretransplant albumin level as normal (≥4.0 g/dL, N = 222, 42%), mild hypoalbuminemia (≥3.5–<4.0 g/dL, N = 190, 36%), and moderate hypoalbuminemia (<3.5 g/dL, N = 120, 23%). Kidney delayed graft function (DGF), length of stay (LOS) after transplant, re-hospitalization within 30 days after discharge, and need for a return to the operating room (OR) related to transplant surgical complications, acute rejection, and uncensored and death-censored graft failure, within the first years post-transplant were outcomes of interest. A total of 532 SPK recipients were included. Mild or moderate hypoalbuminemia was not associated with DGF, LOS, re-hospitalization, or return to the OR in unadjusted or adjusted analyses. Similarly, mild or moderate hypoalbuminemia was not associated with a risk of graft rejection or graft failure. Among SPK recipients, pre-transplant hypoalbuminemia was not associated with worse outcomes and should not be the determining factor in selecting patients for SPK transplant.
format Article
id doaj-art-10e27c75244f4191a3a6afb6635caae9
institution Kabale University
issn 1432-2277
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Transplant International
spelling doaj-art-10e27c75244f4191a3a6afb6635caae92025-01-20T15:30:44ZengFrontiers Media S.A.Transplant International1432-22772025-01-013810.3389/ti.2025.1409114091Pre-Transplant Hypoalbuminemia Is Not Associated With Early Key Outcomes Among Simultaneous Pancreas and Kidney Transplant RecipientsEkaterina Fedorova0Sofia Nehring Firmino1Dixon B. Kaufman2Jon S. Odorico3David Aufhauser4Carrie Thiessen5David P. Al-Adra6Didier Mandelbrot7Brad C. Astor8Brad C. Astor9Sandesh Parajuli10Division of Transplant Surgery, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, United StatesUniversity of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, United StatesDivision of Transplant Surgery, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, United StatesDivision of Transplant Surgery, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, United StatesDivision of Transplant Surgery, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, United StatesDivision of Transplant Surgery, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, United StatesDivision of Transplant Surgery, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, United StatesDivision of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, United StatesDivision of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, United StatesDepartment of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI, United StatesDivision of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, United StatesThe role of pre-transplant hypoalbuminemia and its impact on post-transplant outcomes in patients undergoing simultaneous pancreas-kidney (SPK) transplantation remains unclear. We analyzed all SPK recipients at our center, who had at least 2 weeks of pancreas and kidney graft survival and had serum albumin measured within 45 days pre-transplant. Recipients were categorized based on pretransplant albumin level as normal (≥4.0 g/dL, N = 222, 42%), mild hypoalbuminemia (≥3.5–<4.0 g/dL, N = 190, 36%), and moderate hypoalbuminemia (<3.5 g/dL, N = 120, 23%). Kidney delayed graft function (DGF), length of stay (LOS) after transplant, re-hospitalization within 30 days after discharge, and need for a return to the operating room (OR) related to transplant surgical complications, acute rejection, and uncensored and death-censored graft failure, within the first years post-transplant were outcomes of interest. A total of 532 SPK recipients were included. Mild or moderate hypoalbuminemia was not associated with DGF, LOS, re-hospitalization, or return to the OR in unadjusted or adjusted analyses. Similarly, mild or moderate hypoalbuminemia was not associated with a risk of graft rejection or graft failure. Among SPK recipients, pre-transplant hypoalbuminemia was not associated with worse outcomes and should not be the determining factor in selecting patients for SPK transplant.https://www.frontierspartnerships.org/articles/10.3389/ti.2025.14091/fullhypoalbuminemiaSPKDGFpatient survivalgraft survival
spellingShingle Ekaterina Fedorova
Sofia Nehring Firmino
Dixon B. Kaufman
Jon S. Odorico
David Aufhauser
Carrie Thiessen
David P. Al-Adra
Didier Mandelbrot
Brad C. Astor
Brad C. Astor
Sandesh Parajuli
Pre-Transplant Hypoalbuminemia Is Not Associated With Early Key Outcomes Among Simultaneous Pancreas and Kidney Transplant Recipients
Transplant International
hypoalbuminemia
SPK
DGF
patient survival
graft survival
title Pre-Transplant Hypoalbuminemia Is Not Associated With Early Key Outcomes Among Simultaneous Pancreas and Kidney Transplant Recipients
title_full Pre-Transplant Hypoalbuminemia Is Not Associated With Early Key Outcomes Among Simultaneous Pancreas and Kidney Transplant Recipients
title_fullStr Pre-Transplant Hypoalbuminemia Is Not Associated With Early Key Outcomes Among Simultaneous Pancreas and Kidney Transplant Recipients
title_full_unstemmed Pre-Transplant Hypoalbuminemia Is Not Associated With Early Key Outcomes Among Simultaneous Pancreas and Kidney Transplant Recipients
title_short Pre-Transplant Hypoalbuminemia Is Not Associated With Early Key Outcomes Among Simultaneous Pancreas and Kidney Transplant Recipients
title_sort pre transplant hypoalbuminemia is not associated with early key outcomes among simultaneous pancreas and kidney transplant recipients
topic hypoalbuminemia
SPK
DGF
patient survival
graft survival
url https://www.frontierspartnerships.org/articles/10.3389/ti.2025.14091/full
work_keys_str_mv AT ekaterinafedorova pretransplanthypoalbuminemiaisnotassociatedwithearlykeyoutcomesamongsimultaneouspancreasandkidneytransplantrecipients
AT sofianehringfirmino pretransplanthypoalbuminemiaisnotassociatedwithearlykeyoutcomesamongsimultaneouspancreasandkidneytransplantrecipients
AT dixonbkaufman pretransplanthypoalbuminemiaisnotassociatedwithearlykeyoutcomesamongsimultaneouspancreasandkidneytransplantrecipients
AT jonsodorico pretransplanthypoalbuminemiaisnotassociatedwithearlykeyoutcomesamongsimultaneouspancreasandkidneytransplantrecipients
AT davidaufhauser pretransplanthypoalbuminemiaisnotassociatedwithearlykeyoutcomesamongsimultaneouspancreasandkidneytransplantrecipients
AT carriethiessen pretransplanthypoalbuminemiaisnotassociatedwithearlykeyoutcomesamongsimultaneouspancreasandkidneytransplantrecipients
AT davidpaladra pretransplanthypoalbuminemiaisnotassociatedwithearlykeyoutcomesamongsimultaneouspancreasandkidneytransplantrecipients
AT didiermandelbrot pretransplanthypoalbuminemiaisnotassociatedwithearlykeyoutcomesamongsimultaneouspancreasandkidneytransplantrecipients
AT bradcastor pretransplanthypoalbuminemiaisnotassociatedwithearlykeyoutcomesamongsimultaneouspancreasandkidneytransplantrecipients
AT bradcastor pretransplanthypoalbuminemiaisnotassociatedwithearlykeyoutcomesamongsimultaneouspancreasandkidneytransplantrecipients
AT sandeshparajuli pretransplanthypoalbuminemiaisnotassociatedwithearlykeyoutcomesamongsimultaneouspancreasandkidneytransplantrecipients